Immuno-oncology: a French-Japanese webinar on anti-cancer vaccines and the eradication of chronic inflammation

The French National Cancer Institute and the National Cancer Center (NCC) of Japan are organising five webinars on immuno-oncology throughout 2022. The next webinar will be held on May 10. It will focus on anti-cancer vaccines and eradicating chronic inflammation.

The Institute is organising a series of webinars on immuno-oncology in collaboration with the National Cancer Center (NCC) of Japan and with the support of of the Office for Science and Technology of the French Embassy to Japan and a grant from the Kiyoko Goto and Paul Bourdarie Cancer Foundation. A French and a Japanese speaker will present their research work during these webinars.

The third session of this five-part series will be held on May 10, 2022, with presentations by Prof. Eric Tartour (Georges Pompidou European Hospital - APHP) and Prof. Masanori Hatakeyama (Graduate School of Medicine, University of Tokyo - Japan). It will focus on the relevance of targeting memory T cells to develop new anti-HPV vaccines and on the Japanese expertise in tackling H. pylori-related inflammation and cancers.

This international scientific meeting will be held online:

  • from 10:00 am to 12.00 am (CET);
  • from 5:00 pm to 7:00 pm (JST).

For more details, this webinar’s programme is available online.

Session on Cellular Cancer Therapies: access the replay

The second session of these webinars was held on March 10 and focused on cell-based cancer therapies. The speakers were Dr Sebastian Amigorena (Institut Curie, Paris) and Dr Yuki Kagoya (Aichi Cancer Center Research Institute - Japan).

Caption - March 10 Webinar

Dr Amigorena presented his work on the epigenetic reprogramming of CAR-T cells by Suv39h1 ablation while Dr Kagoya's presentation focused on the genetic modification of CAR-T cells for optimal cancer immunotherapy.

Moderated by Dr Alain Eychene, Director of French National Cancer Institute, and Dr. Hiroyuki Mano, Director of National Cancer Center Research Institute, this outstanding session enabled to attend high scientific quality presentations and fuelled enriching exchanges, further strengthening the complementarity between the two talks.

Access this webinar's replay (registration required)